Atezolizumab shows similar efficacy in upper tract urothelial carcinoma and standard bladder cancer
Median overall survival is the same for both malignancies, study results show.
Pandemic exacts economic toll on urology practices
As practices reboot, urologists consider leaner staffs and operations.
Denosumab tops spending for common urology Part B drugs
Mitomycin sees the largest annual growth in spending per dose over the past 5 years, Robert A. Dowling, MD, reports.
How to code for a perineal prostate biopsy
Three codes are available for prostate biopsy, but only one is typically used for perineal biopsy, according to Jonathan Rubenstein, MD, and Mark Painter.
